Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Krish Krishnan Insider Profile
4 Followers
Krish Krishnan, COO at Precigen, holds 3.15M shares in Krystal Biotech (Ticker: KRYS), holds 113.31K shares in Precigen (Ticker: PGEN).
Profitable Transactions
4 out of 7 Profitable Transactions
Average Return
+43.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Krish Krishnan holds in companies
Most Profitable Insider Trade
The most profitable trade made by Krish Krishnan
Krish Krishnan's Trading History
Precigen
Feb 01, 2016
COO
Uninformative Buy
201.68K
$86.35K
Krystal Biotech
Dec 13, 2024
President & CEO, Director, Ten Percent Owner
Uninformative Sell
8.13M
$519.73M
List of latest transactions for each holding click on a transaction to see Krish Krishnan's performance on stock
You May Also Like
Krish Krishnan insider profile FAQ
What is the percentage of profitable transactions made by Krish Krishnan?
The percentage of profitable transactions made by Krish Krishnan is 57%.
What is the average return per transaction made by Krish Krishnan?
The average return per transaction made by Krish Krishnan is 43.40%.
What stocks does Krish Krishnan hold?
Krish Krishnan holds: PGEN, KRYS stocks.
What was Krish Krishnan’s latest transaction?
Krish Krishnan latest transaction was an Uninformative Sell of $8.13M.
What was Krish Krishnan's most profitable transaction?
Krish Krishnan’s most profitable transaction was an Informative Buy of PGEN stock on May 13, 2014. The return on the trade was 170.70%.
What is Krish Krishnan's role in Precigen?
Krish Krishnan's role in Precigen is COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.